No Data
No Data
Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?
How Is The Market Feeling About Viking Therapeutics?
Viking Therapeutics Analyst Ratings
B.Riley Financial Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $109
Viking Therapeutics: Strong Potential in Obesity and Type 2 Diabetes Market With Innovative VK2735 Program
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
No Data
No Data
HugoV : Yes on our way to 90
Hanh Tran384 OP HugoV : Can’t wait!!!